Quarry LP’s Eton Pharmaceutcials ETON Stock Holding History

Quarry LP’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,700	Closed	-$36.9K	–	2281
2025 Q3	$36.9K	Buy	+1,700	New	+$28.2K	0.01%	1022

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Quarry LP's ETON Position: Q4 2025 in Review

Quarry LP sold out of Eton Pharmaceutcials (ETON) in Q4 2025, closing a stake of 1,700 shares — an estimated $36.9K sold.

Quarry LP first reported a position in ETON in Q3 2025 and held it in 1 quarter. The position peaked at $36.9K in Q3 2025. 104 funds tracked by Wall St. Rank hold ETON as of Q4 2025.

Quarry LP reported no remaining Eton Pharmaceutcials position as of Q4 2025 after selling out during the quarter.
Quarry LP sold 1,700 Eton Pharmaceutcials shares in Q4 2025, an estimated $36.9K.
Quarry LP first reported a position in Eton Pharmaceutcials in Q3 2025 and held it in 1 quarter.
Quarry LP's Eton Pharmaceutcials position peaked at $36.9K in Q3 2025.
104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.